European Society of Toxicologic Pathology—Pathology 2.0 Mass Spectrometry Imaging Special Interest Group: Mass Spectrometry Imaging in Diagnostic and Toxicologic Pathology for Label-Free Detection of Molecules—From Basics to Practical Applications
Authors:
- Enrico VezzaliEVEnrico Vezzali
- Fernando Romero-PalomoFRFernando Romero-Palomo
- Marjolein van HeerdenMHMarjolein van Heerden
- Caroline ChipeauxCCCaroline Chipeaux
- Gregory HammGHGregory Hamm
- Dinesh S. BangariDBDinesh S. Bangari
- Barbara LenzBLBarbara Lenz
- Bogdan MunteanuBMBogdan Munteanu
- Bhanu SinghBSBhanu Singh
- Celine ThuilliezCTCeline Thuilliez
- 1 January 2025
- journal article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 53 (1) , 130-158
Abstract
Mass Spectrometry Imaging (MSI) is a powerful tool to understand molecular pathophysiology and therapeutic and toxicity mechanisms, as well as for patient stratification and precision medicine. MSI, a label-free technique offering detailed spatial information on a large number of molecules in different tissues, encompasses various techniques including Matrix-Assisted Laser Desorption Ionization (MALDI), Desorption Electrospray Ionization (DESI), and Secondary Ion Mass Spectrometry (SIMS) that can be applied in diagnostic and toxicologic pathology. Given the utmost importance of high-quality samples, pathologists play a pivotal role in providing comprehensive pathobiology and histopathology knowledge, as well as information on tissue sampling, orientation, morphology, endogenous biomarkers, and pathogenesis, which are crucial for the correct interpretation of targeted experiments. This article introduces MSI and its fundamentals, and reports on case examples, determining the best suited technology to address research questions. High-level principles and characteristics of the most used modalities for spatial metabolomics, lipidomics and proteomics, sensitivity and specific requirements for sample procurement and preparation are discussed. MSI applications for projects focused on drug metabolism, nonclinical safety assessment, and pharmacokinetics/pharmacodynamics and various diagnostic pathology cases from nonclinical and clinical settings are showcased.Keywords
This publication has 50 references indexed in Scilit:
- Mass spectrometry imaging protocol for spatial mapping of lipids, N ‐glycans and peptides in murine lung tissueRapid Communications in Mass Spectrometry, 2024
- Mass spectrometry in ocular drug researchMass Spectrometry Reviews, 2023
- High-Resolution Imaging Mass Spectrometry of Human Donor Eye: Photoreceptors Cells and Basal Laminar Deposit of Age-Related Macular Degeneration2023
- Desorption electrospray ionization and matrix-assisted laser desorption/ionization as imaging approaches for biological samples analysisAnalytical and Bioanalytical Chemistry, 2023
- Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessmentArchives of Toxicology, 2022
- Removing Formaldehyde‐Induced Peptidyl Crosslinks Enables Mass Spectrometry Imaging of Peptide Hormone Distributions from Formalin‐Fixed Paraffin‐Embedded TissuesAngewandte Chemie International Edition, 2020
- Liquid Extraction Surface Analysis (LESA) High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) Mass Spectrometry for In Situ Analysis of Intact Proteins2019
- A recommended and verified procedure for in situ tryptic digestion of formalin‐fixed paraffin‐embedded tissues for analysis by matrix‐assisted laser desorption/ionization imaging mass spectrometryJournal of Mass Spectrometry, 2019
- Intramuscular Administration of Paliperidone Palmitate Extended-Release Injectable Microsuspension Induces a Subclinical Inflammatory Reaction Modulating the Pharmacokinetics in RatsJournal of Pharmaceutical Sciences, 2014
- High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometryProteomics, 2008